Science To Consumers Performance
| BEUTDelisted Stock | USD 0.0001 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Science To are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Science To Consumers has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Science To is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Science |
Science To Relative Risk vs. Return Landscape
If you would invest 0.01 in Science To Consumers on November 6, 2025 and sell it today you would earn a total of 0.00 from holding Science To Consumers or generate 0.0% return on investment over 90 days. Science To Consumers is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Science, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Science To Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Science To for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Science To Consumers can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Science To Consumers is not yet fully synchronised with the market data | |
| Science To Consumers generated a negative expected return over the last 90 days | |
| Science To Consumers has some characteristics of a very speculative penny stock | |
| Science To Consumers has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Science To until it has trouble settling it off, either with new capital or with free cash flow. So, Science To's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Science To Consumers sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Science to invest in growth at high rates of return. When we think about Science To's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (58.7 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Science To Consumers currently holds about 1.44 K in cash with (47.69 K) of positive cash flow from operations. | |
| Roughly 66.0% of the company shares are held by company insiders |
Science To Fundamentals Growth
Science Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Science To, and Science To fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Science Pink Sheet performance.
| Return On Asset | -4.4 | |||
| Current Valuation | 1.18 M | |||
| Shares Outstanding | 31.92 M | |||
| Price To Earning | (17.50) X | |||
| Price To Book | 955.49 X | |||
| EBITDA | (51.17 K) | |||
| Cash And Equivalents | 1.44 K | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (47.69 K) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 11.73 K | |||
| Retained Earnings | (162 K) | |||
| Current Asset | 2 K | |||
| Current Liabilities | 68 K | |||
About Science To Performance
Assessing Science To's fundamental ratios provides investors with valuable insights into Science To's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Science To is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Science to Consumers, Inc., a development stage company, focuses on marketing and selling formulated anti-aging cream products under the DermaLastyl name and distributing Argan oil products. Science to Consumers, Inc. was founded in 2013 and is based in Guangzhou, China. Science To is traded on OTC Exchange in the United States.Things to note about Science To Consumers performance evaluation
Checking the ongoing alerts about Science To for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Science To Consumers help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Science To Consumers is not yet fully synchronised with the market data | |
| Science To Consumers generated a negative expected return over the last 90 days | |
| Science To Consumers has some characteristics of a very speculative penny stock | |
| Science To Consumers has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Science To until it has trouble settling it off, either with new capital or with free cash flow. So, Science To's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Science To Consumers sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Science to invest in growth at high rates of return. When we think about Science To's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (58.7 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Science To Consumers currently holds about 1.44 K in cash with (47.69 K) of positive cash flow from operations. | |
| Roughly 66.0% of the company shares are held by company insiders |
- Analyzing Science To's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Science To's stock is overvalued or undervalued compared to its peers.
- Examining Science To's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Science To's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Science To's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Science To's pink sheet. These opinions can provide insight into Science To's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Science Pink Sheet
If you are still planning to invest in Science To Consumers check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science To's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |